2001
DOI: 10.1177/000313480106700910
|View full text |Cite
|
Sign up to set email alerts
|

Mesenteric Ischemia: An Unusual Presentation of Traumatic Intrahepatic Arterioportal Fistula

Abstract: Traumatic hepatic arterioportal fistulae (APF) are described infrequently as sequelae of hepatic trauma. These anomalies are usually associated with blunt hepatic trauma or iatrogenic injury. The majority of APF present within weeks to months of injury with gastrointestinal hemorrhage, hemobilia, abdominal pain, and diarrhea. When presenting remotely APFs are associated with portal hypertension, heart failure, gastrointestinal hemorrhage, ascites, and splenomegaly. We report an unusual case of mesenteric ische… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2004
2004
2022
2022

Publication Types

Select...
3
3

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(1 citation statement)
references
References 13 publications
0
1
0
Order By: Relevance
“…Less than 10% of all arterioportal fistulae that involve the hepatic artery are congenital (1). Secondary causes of IAPF are more common and well described, including major blunt (7,8) or penetrating (9‐11) abdominal trauma, surgical procedures such as needle liver biopsy (12‐14), Kasai portoenterostomy (15‐17) and segmental liver transplantation (18), hepatic artery aneurysm (14,19), cirrhosis (20‐22), hepatocellular carcinoma (23‐25), biliary atresia (26) and hereditary hemorrhagic telangiectasia (27‐30).…”
Section: Discussionmentioning
confidence: 99%
“…Less than 10% of all arterioportal fistulae that involve the hepatic artery are congenital (1). Secondary causes of IAPF are more common and well described, including major blunt (7,8) or penetrating (9‐11) abdominal trauma, surgical procedures such as needle liver biopsy (12‐14), Kasai portoenterostomy (15‐17) and segmental liver transplantation (18), hepatic artery aneurysm (14,19), cirrhosis (20‐22), hepatocellular carcinoma (23‐25), biliary atresia (26) and hereditary hemorrhagic telangiectasia (27‐30).…”
Section: Discussionmentioning
confidence: 99%